We are a research-driven biotechnology spin-off from the Medical University of Innsbruck; our research aim centers around the function of the vitamin E-binding protein afamin and its very promising diagnostic and therapeutic applications in major medical areas such as cancer, infertility, cardiovascular and neurodegenerative diseases.
